Ian Clements

Insider Reports History

Location
C/O Mirum Pharmaceuticals, Inc., 950 Tower Lane, Suite 1050, Foster City, CA
Signature
/s/ Jody Howe, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ian Clements:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. Chief Financial Officer Common Stock 30K $841K $28.04 Nov 10, 2022 Direct
Mirum Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 60K Jan 6, 2022 Direct

Insider Reports Filed by Ian Clements

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MIRM Mirum Pharmaceuticals, Inc. Nov 10, 2022 1 $5.54K 4 Nov 14, 2022 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. May 10, 2022 1 $15.3K 4 May 12, 2022 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. Jan 6, 2022 2 $0 4 Jan 7, 2022 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. Nov 24, 2021 2 $20.5K 4 Nov 29, 2021 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. Nov 10, 2021 1 $6.19K 4 Nov 15, 2021 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. Sep 29, 2021 2 -$30.3K 4 Oct 1, 2021 Chief Financial Officer
MIRM Mirum Pharmaceuticals, Inc. May 10, 2021 1 $14.3K 4 May 12, 2021 Chief Financial Officer